Application Sponsors
ANDA 091342 | LANNETT CO INC | |
Marketing Status
Application Products
001 | SOLUTION;ORAL | EQ 4MG BASE/5ML | 0 | ONDANSETRON HYDROCHLORIDE | ONDANSETRON HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2011-01-27 | |
LABELING; Labeling | SUPPL | 3 | AP | 2015-01-14 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 2016-03-03 | UNKNOWN |
LABELING; Labeling | SUPPL | 5 | AP | 2018-03-14 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2018-03-14 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2022-06-23 | STANDARD |
| SUPPL | 27 | AP | 2011-01-27 | |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 3 | Null | 15 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 7 |
SUPPL | 6 | Null | 7 |
SUPPL | 8 | Null | 7 |
SUPPL | 27 | Null | 0 |
TE Codes
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 91342
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"ONDANSETRON HYDROCHLORIDE","activeIngredients":"ONDANSETRON HYDROCHLORIDE","strength":"EQ 4MG BASE\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ONDANSETRON HYDROCHLORIDE","submission":"ONDANSETRON HYDROCHLORIDE","actionType":"EQ 4MG BASE\/5ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)